Why the study?
Does quinic acid attenuate cisplatin-induced acute kidney injury in a rat model?
Population
40 male Wistar rats
Comparison
Quinic acid administered orally at doses of 25… vs Cisplatin alone and untreated control
Design
Preclinical, randomly divided, blinded scoring for renal histopathology
Follow-up
14 days
Key result
Quinic acid (particularly at 50 and 100 mg/kg) significantly attenuated cisplatin-induced acute kidney injury by improving renal markers, restoring antioxidant capacity, and reducing inflammation.
Authors
Loading...
QA attenuates cisplatin AKI in rats; leaves open translation to human chemotherapy patients.
RCT (n=40)
Single-blind
Randomly divided
Does quinic acid attenuate cisplatin-induced acute kidney injury in a rat model?
Quinic acid demonstrates nephroprotective effects against cisplatin-induced acute kidney injury in rats through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms.
Goudarzi et al. (2026) conducted an RCT in Cisplatin-induced acute kidney injury (n=40). Quinic acid vs. Cisplatin alone and healthy control was evaluated on Biochemical markers of renal dysfunction, oxidative stress indices, inflammatory cytokines, apoptotic gene expression, and Nrf2 pathway proteins. Quinic acid (particularly at 50 and 100 mg/kg) significantly attenuated cisplatin-induced acute kidney injury by improving renal markers, restoring antioxidant capacity, and reducing inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: